Reply

Open Access

Publisher Website

29 November 2005

journal article
other
Published by Wolters Kluwer Health in Hepatology

Vol. 42 (6), 1459-1460
https://doi.org/10.1002/hep.20977

Abstract

No abstract available

This publication has 9 references indexed in Scilit:

A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B
Gastroenterology, 2005
Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B
New England Journal of Medicine, 2005
424 Durability of HBEAG seroconversion after adefovir dipivoxil treatment for chronic hepatitis B (CHB)
Journal of Hepatology, 2004
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
New England Journal of Medicine, 2004
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B
Hepatology, 2004
Durability of Serologic Response After Lamivudine Treatment of Chronic Hepatitis B
Hepatology, 2003
Histological outcome during long-term lamivudine therapy
Gastroenterology, 2003
Extended Lamivudine Treatment in Patients With Chronic Hepatitis B Enhances Hepatitis B E Antigen Seroconversion Rates: Results After 3 Years of Therapy
Hepatology, 2001
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
Gastroenterology, 2000

Cited by 1 article